Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,321,000 | 7,947,000 | 9,440,000 | 12,282,000 | 6,083,000 |
| Marketable Securities | 4,612,000 | N/A | N/A | N/A | 7,809,000 |
| Receivables | 5,343,000 | 5,137,000 | 5,091,000 | 4,858,000 | 4,851,000 |
| Inventories | 3,725,000 | 3,889,000 | 3,968,000 | 3,470,000 | 3,558,000 |
| Other current assets | 1,442,000 | 1,503,000 | 1,615,000 | 1,653,000 | 1,619,000 |
| TOTAL | $21,443,000 | $18,476,000 | $20,114,000 | $22,263,000 | $23,920,000 |
| Non-Current Assets | |||||
| PPE Net | 8,679,000 | N/A | N/A | N/A | 8,497,000 |
| Investments And Advances | 7,086,000 | 0 | 0 | 0 | 7,450,000 |
| Intangibles | 13,294,000 | 0 | 0 | 0 | 5,629,000 |
| Other Non-Current Assets | 7,230,000 | 36,194,000 | 32,929,000 | 27,383,000 | 6,992,000 |
| TOTAL | $36,289,000 | $36,194,000 | $32,929,000 | $27,383,000 | $28,568,000 |
| Total Assets | $57,732,000 | $54,670,000 | $53,043,000 | $49,646,000 | $52,488,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,135,000 | 4,467,000 | 5,201,000 | 3,455,000 | 4,119,000 |
| Accounts payable and accrued liabilities | 1,961,000 | 1,773,000 | 1,965,000 | 1,843,000 | 2,020,000 |
| Other current liabilities | 4,979,000 | 6,113,000 | 5,373,000 | 5,920,000 | 4,609,000 |
| TOTAL | $15,328,000 | $12,353,000 | $12,539,000 | $11,218,000 | $11,849,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,319,000 | 2,435,000 | 2,493,000 | 2,592,000 | 2,736,000 |
| Other Non-Current Liabilities | 4,447,000 | 8,127,000 | 7,602,000 | 6,368,000 | 4,245,000 |
| TOTAL | $9,240,000 | $10,569,000 | $10,101,000 | $8,956,000 | $9,324,000 |
| Total Liabilities | $24,568,000 | $22,922,000 | $22,640,000 | $20,174,000 | $21,173,000 |
| Shareholders' Equity | |||||
| Common Shares | 994,000 | N/A | N/A | N/A | 1,008,000 |
| Retained earnings | 32,142,000 | N/A | N/A | N/A | 30,328,000 |
| Other shareholders' equity | 174,000 | 31,748,000 | 30,403,000 | 29,472,000 | 138,000 |
| TOTAL | $33,164,000 | $31,748,000 | $30,403,000 | $29,472,000 | $31,315,000 |
| Total Liabilities And Equity | $57,732,000 | $54,670,000 | $53,043,000 | $49,646,000 | $52,488,000 |